" " Presented by David Browning, MD, PhD

Learning Objectives: 

  • Evaluate a proposal from a drug company to offer a "rebate" on a drug provided in office.
  • Evaluate hospital rules regarding thresholds for surgery in indigent patients.
  • Evaluate switching from a low to high cost anti-VEGF drug of similar efficacy.
Session date: 
02/13/2026 - 8:30am EST to 04/14/2026 - 11:59am EDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Live activity is designated for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

  • 1.00 Participation
    UK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.
Please login or register to take this course.
Faculty List: 
Speaker(s)

david browning, MD, PhD; Associate Professor at Wake Forest University School of Medicine

has a financial relationship (Copyright) with Springer Inc;.
has a financial relationship (Stock) with Zeiss Meditec;.